Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005290938 | SCV005961436 | uncertain significance | not specified | 2025-01-08 | criteria provided, single submitter | clinical testing | The c.1717A>G (p.I573V) alteration is located in exon 15 (coding exon 15) of the AXL gene. This alteration results from a A to G substitution at nucleotide position 1717, causing the isoleucine (I) at amino acid position 573 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |